Astragalus

R125.00

No tax

A tincture made from the root of the Astragalus (Astragalus membranaceus) plant

Please read the 'Description' tab below

Description
Product Details

Be Informed - Please Read This Basic Research Overview Before You Buy

Disclaimer: The information contained herein should NOT be construed as an exhaustive nor professional research paper. It is simply a short overview to give you a basic idea about the product. The onus is still on YOU to decide if you can or should use this product or not. Please also read our Legal Notice HERE

Astragalus membranaceus Root: Traditional Uses, Safety Profile, and Clinical Considerations

Astragalus membranaceus, commonly known as Huang Qi in traditional Chinese medicine (TCM), has been a cornerstone of herbal therapeutics for over 2,000 years. Renowned for its adaptogenic and immunomodulatory properties, the root of this plant has been extensively utilized across diverse medical systems to enhance vitality, combat inflammation, and support organ function. This report synthesizes historical applications, phytochemical insights, and contemporary clinical evidence to evaluate the root’s therapeutic potential, safety concerns, and contraindications.

Historical Context and Ethnobotanical Significance

Etymology and Folk Nomenclature

The term Huang Qi (黃芪) translates to "yellow leader," reflecting the root’s yellow hue and its status as a premier tonic in TCM. Regionally, it is also termed Bei Qi (北芪) in northern China and Mongolian milkvetch in English-speaking regions. In Mongolia, it is known as Хунчир (Hunchir), while indigenous African names include bofepha (Sotho) and ubuvuma (Xhosa). The scientific synonym Astragalus mongholicus underscores its geographic prevalence in Mongolia and northern China^[1]^[2].

Historical Applications

First documented in Shennong’s Classic of Materia Medica (circa 200 BCE), Astragalus root was classified as a superior herb for replenishing Qi (vital energy) and fortifying the Wei Qi (defensive energy)^[2]^[3]. Historical texts describe its use in treating fatigue, night sweats, and chronic ulcers, often combined with herbs like Ginseng and Licorice. In Mongolian medicine, it was employed to stabilize metabolic disorders and enhance resilience to environmental stressors^[1]^[3].

Traditional Medicinal Applications

Immune System Modulation

Astragalus root is revered as a potent immunostimulant. Traditional preparations (decoctions, powders) were administered to prevent recurrent infections and accelerate recovery from illness. Modern studies validate its ability to increase white blood cell production, enhance macrophage activity, and upregulate interferon-gamma secretion^[4]^[5]^[6]. These effects are attributed to polysaccharides (e.g., astragalan) and saponins (e.g., astragaloside IV), which activate Toll-like receptors and NF-κB pathways^[4]^[2]^[3].

Cardiovascular and Metabolic Support

In TCM, Astragalus root is prescribed for Qi deficiency patterns manifesting as palpitations, edema, and lethargy. Clinical trials note its capacity to improve ejection fraction in heart failure patients by 8–12% and reduce LDL cholesterol through triterpene-mediated AMPK activation^[3]^[7]. Diabetic applications include lowering fasting blood glucose by 15–20% via enhanced GLUT4 translocation and pancreatic β-cell protection^[6]^[7].

Anti-Inflammatory and Antioxidant Effects

The root’s flavonoids (e.g., calycosin) inhibit cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX), reducing prostaglandin E₂ and leukotriene B₄ synthesis^[4]^[8]. In rheumatoid arthritis models, oral administration decreased IL-6 and TNF-α levels by 40–60%, comparable to low-dose prednisolone^[4]^[8]. Antioxidant activity, measured via DPPH radical scavenging, exceeds 80% at 100 μg/mL concentrations, mitigating oxidative stress in chronic kidney disease^[2]^[9].

Safety Profile and Adverse Effects

Gastrointestinal and Hepatic Reactions

While generally well-tolerated, high doses (>60 g/day) may induce nausea, diarrhea, or epigastric discomfort in 5–10% of users^[5]^[10]. Subchronic toxicity studies in rats (5.7–39.9 g/kg) revealed no histopathological changes, but human case reports note transient ALT/AST elevations in 2% of subjects, resolving upon discontinuation^[11]^[10]. Notably, a 2024 study identified Astragalus polysaccharide’s role in mitigating voriconazole-induced hepatotoxicity via CYP2C19 induction, suggesting context-dependent hepatic effects^[12].

Immunological Risks

Astragalus’s immunostimulatory properties pose risks for autoimmune conditions. In lupus-prone mice, supplementation exacerbated anti-dsDNA antibody production by 30%, while clinical trials report rare instances of psoriasis flare-ups^[10]^[13]. Concurrent use with immunosuppressants (e.g., cyclosporine) may reduce drug efficacy by 20–40%, necessitating therapeutic monitoring^[5]^[14].

Endocrine and Reproductive Concerns

Phytoestrogenic isoflavones (e.g., formononetin) bind weakly to estrogen receptors (EC₅₀ = 10⁻⁶ M), raising theoretical risks for hormone-sensitive cancers. Rodent studies indicate increased uterine weight at 500 mg/kg doses, though human data remain inconclusive^[9]^[10]. Contraindications during pregnancy stem from traditional abortifacient use and limited safety data; in utero exposure in rats correlated with 12% higher fetal resorption rates^[15]^[13].

Contraindications and Drug Interactions

Absolute Contraindications

· Autoimmune disorders: Multiple sclerosis, rheumatoid arthritis, and Graves’ disease due to immune hyperactivation^[5]^[13].

· Organ transplants: Risk of graft rejection with concomitant tacrolimus or mycophenolate^[16]^[14].

· Pregnancy/Lactation: Potential teratogenicity and lactation suppression per traditional and preclinical evidence^[15]^[13].

Clinically Significant Interactions

Drug Class	Interaction Mechanism	Clinical Outcome
Immunosuppressants	Antagonism of calcineurin inhibitors	Reduced trough levels by 15–30%^[14]
Antidiabetics	Enhanced insulin sensitivity	Hypoglycemia risk (RR = 2.1)^[10]^[7]
Anticoagulants	Inhibition of platelet aggregation	Prolonged INR (1.5–2.0)^[5]^[10]
Chemotherapy	Upregulation of P-glycoprotein	Reduced doxorubicin efficacy^[9]^[3]

Conclusion

Astragalus membranaceus root embodies a dual legacy of profound therapeutic potential and nuanced risk profiles. While its immunomodulatory and cardioprotective effects align with centuries of ethnomedical use, modern pharmacology demands cautious application in susceptible populations. Clinicians must weigh benefits against risks of hepatotoxicity, autoimmune exacerbation, and drug interactions, particularly in polypharmacy scenarios. Future research should prioritize standardized extracts and long-term safety surveillance to optimize its integration into evidence-based practice.

^[17]^[4]^[1]^[2]^[5]^[16]^[11]^[14]^[12]^[9]^[15]^[10]^[6]^[8]^[13]^[3]^[7]